Initial Evaluation and Management of a Lung Mass
Clinical Assessment
- The American College of Chest Physicians recommends performing a physical examination with attention to respiratory status, lymphadenopathy, and signs of paraneoplastic syndromes 1, 2
- Screen for symptoms suggesting metastatic disease, such as headache, bone pain, and neurological deficits, in patients with a lung mass 3, 4
Initial Diagnostic Testing
- The American College of Chest Physicians recommends ordering a contrast-enhanced CT scan of the chest as the primary imaging modality for patients with a lung mass 1, 2
- Obtain basic laboratory tests, including complete blood count, comprehensive metabolic panel, liver function tests, and calcium levels, for patients with a lung mass 1, 2, 3
Evaluation for Metastatic Disease
- Use a standardized clinical screening approach to guide further imaging for metastases, rather than routine imaging for all patients with a lung mass 3, 4
- Clinical factors suggesting metastatic disease include significant weight loss 5, bone pain 4, and abnormal laboratory values, such as anemia, elevated liver enzymes, and hypercalcemia 3, 4, 7
- For patients with clinical stage I and II lung cancer without abnormalities on clinical screening, additional imaging for metastases may be unnecessary 3, 4
- For patients with advanced clinical stage (IIIA and IIIB) or with mediastinal (N2) involvement, consider additional imaging even without clinical symptoms of metastatic disease 4, 7
Assessment of Paraneoplastic Syndromes
- Evaluate for paraneoplastic syndromes, which can be categorized as hormonally-based or immunologically-based, in patients with a lung mass 6
- Common paraneoplastic syndromes in lung cancer include ectopic Cushing syndrome, syndrome of inappropriate antidiuretic hormone (SIADH), and neurological paraneoplastic syndromes, such as Anti-Hu syndrome 5, 6
- Early recognition and treatment of paraneoplastic syndromes can limit morbidity and facilitate more effective cancer treatment 5, 6
Multidisciplinary Approach
- Refer patients with a lung mass to a multidisciplinary team with representatives from pulmonary medicine, thoracic surgery, medical oncology, radiation oncology, palliative care, radiology, and pathology 2, 8
- The multidisciplinary approach is particularly important for patients requiring multimodality therapy 2, 8
Common Pitfalls to Avoid
- Overlooking paraneoplastic syndromes that may impact treatment options and outcomes in patients with a lung mass 5, 6
- Performing unnecessary imaging studies for metastatic disease in early-stage patients without clinical indicators 3, 4
- Delaying multidisciplinary consultation, which can impact timely care delivery for patients with a lung mass 2, 8